Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.49 USD | -9.72% |
|
-4.81% | +72.53% |
| 07-29 | European Equities Traded in US as ADRs Ease in Wednesday Trading | MT |
| 07-28 | European Equities Traded in US as ADRs Ease in Tuesday Trading | MT |
| Market Cap | 368M 495M 431M 401M 695M 47.3B 706M 4.73B 1.85B 23.55B 1.86B 1.82B 78.96B | P/E 2026 * |
-17.5x | P/E 2027 * | -15.6x |
|---|---|---|---|---|---|
| Enterprise Value | 222M 299M 260M 242M 420M 28.55B 426M 2.85B 1.12B 14.21B 1.12B 1.1B 47.66B | EV / Sales 2026 * |
88.4x | EV / Sales 2027 * | 34.4x |
| Free-Float |
69.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | -9.72% | ||
| 1 week | -4.81% | ||
| 1 month | -0.10% | ||
| 3 months | +47.12% | ||
| 6 months | +117.63% | ||
| Current year | +72.53% |
| 1 week | 10.47 |  | 12.19 |
| 1 month | 8.91 | | 12.19 |
| Current year | 4.19 | | 12.19 |
| 1 year | 4.19 | | 12.19 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/6/26 A | Sell | 865,112 | 0.6105% | |||
| 1/2/26 A | Free | Chief Financial Officer | 375,000 | 0.2646% | ||
| 1/2/26 A | Free | Director | 90,000 | 0.0635% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.72% | -4.81% | +70.02% | +101.73% | 495M | |
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | |
| -2.41% | -0.90% | +411.96% | +495.33% | 39.87B | |
| -1.16% | +12.96% | +28.81% | +7.25% | 38.68B | |
| -1.88% | -3.03% | +5.69% | +53.00% | 35.13B | |
| -1.74% | +5.12% | +14.44% | +41.77% | 29.79B | |
| -0.21% | -4.04% | +36.40% | +125.75% | 16.11B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| -0.64% | +2.65% | +3.40% | +13.11% | 13.61B | |
| -1.19% | -1.32% | -1.73% | -34.37% | 12.62B | |
| Average | -2.32% | +0.47% | +63.03% | +90.54% | 25.09B | |
| Weighted average by Cap. | -1.61% | +2.02% | +79.76% | +108.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.51M 3.38M 2.94M 2.74M 4.75M 323M 4.82M 32.27M 12.66M 161M 12.71M 12.43M 539M | 3.47M 4.67M 4.06M 3.78M 6.55M 446M 6.65M 44.53M 17.48M 222M 17.54M 17.15M 744M |
| Net income | -50.4M -67.85M -58.98M -54.9M -95.18M -6.48B -96.66M -647M -254M -3.22B -255M -249M -10.81B | -84.8M -114M -99.24M -92.37M -160M -10.9B -163M -1.09B -427M -5.43B -429M -419M -18.19B |
| Net Debt | -146M -196M -171M -159M -276M -18.75B -280M -1.87B -735M -9.33B -738M -721M -31.3B | -249M -335M -291M -271M -470M -31.97B -477M -3.19B -1.25B -15.92B -1.26B -1.23B -53.37B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | $10.49 | -9.72% | 556,511 |
| 30/07/26 | $11.62 | +0.61% | 769,576 |
| 29/07/26 | $11.55 | -.--% | 595,348 |
| 28/07/26 | $11.55 | -4.31% | 1,190,811 |
| 27/07/26 | $12.07 | +9.53% | 666,332 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
